ALPHA BLOCKERS. Products Affected. Details. Step 2: RAPAFLO 4 MG CAPSULE. Step 1: alfuzosin extended release tablet doxazosin tablet

Similar documents
2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

Contents ALPHA BLOCKERS... 3 COLCRYS-PST... 4 DPP-4 INHIBITORS-PST... 5 HIGH RISK MEDICATIONS - SEDATIVE HYPNOTICS... 6

ALPHA BLOCKERS. Products Affected Step 1: Details. Step 2: Rapaflo 4 mg capsule Rapaflo 8 mg capsule

Drugs That Require Step Therapy (ST) Step Therapy Medications

2018 Step Therapy (ST) Criteria

2017 Step Therapy (ST) Criteria

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications

ALZHEIMER'S DRUGS. Details. Step 2: Exelon Patch 13.3 mg/24 hour transdermal Exelon Patch 4.6 mg/24 hr transdermal

ACYCLOVIR OINT (CCHP2017)

COLCRYS-PST. Products Affected Step 1: Mitigare 0.6 mg capsule. Details. Step 2: Colcrys 0.6 mg tablet

COLCRYS-PST. Products Affected Step 1: Mitigare 0.6 mg capsule. Details. Step 2: Colcrys 0.6 mg tablet

2019 STEP THERAPY CRITERIA UCare Connect + Medicare (SNBC) (HMO SNP) UCare s Minnesota Senior Health Options (MSHO) (HMO SNP)

ACYCLOVIR OINT (CCHP2017)

2018 WPS MedicareRx Plan (PDP) Step Therapy

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017)

2018 STEP THERAPY CRITERIA UCare Connect + Medicare (SNBC) (HMO SNP) UCare s Minnesota Senior Health Options (MSHO) (HMO SNP)

Step Therapy Requirements

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

2017 Step Therapy Criteria

ALLERGIC CONJUNCTIVITIS AGENTS

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO)

ANTICONVULSANT STEP THERAPY

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

Step Therapy Requirements

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+)

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

Step Therapy Requirements

ANTICONVULSANTS. Details

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

ANTICONVULSANTS. Details

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

BYSTOLIC. Products Affected Step 2: BYSTOLIC 10 MG TABLET BYSTOLIC 2.5 MG TABLET. Details BYSTOLIC 20 MG TABLET BYSTOLIC 5 MG TABLET

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements

FirstCarolinaCare Insurance Company. Step Therapy Requirements

2019 PDP Basic Step Therapy Document

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

2018 Step Therapy FID 18088

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

2018 Step Therapy Criteria

Drugs That Require Step Therapy (ST)

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

Drugs That Require Step Therapy (ST)

Drugs That Require Step Therapy (ST)

Step Therapy Requirements. Effective: 05/01/2018

Step Therapy Requirements. Effective: 11/01/2018

2019 Simply Step Therapy Document

SmithRx Standard Formulary Step Therapy List

ADHD STIMULANTS-S(SHC)

ALPHA GLUCOSIDASE INHIBITOR THERAPY

Antidepressant tapering advice

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)

Step Therapy Medications

2015 Chinese Community Health Plan Senior Program (HMO) Step Therapy Criteria Last Updated 11/1/2015

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018.

STEP THERAPY CRITERIA

Step Therapy Criteria

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

Step Therapy Requirements. Effective: 03/01/2015

ANTIDIABETIC AGENTS - MISCELLANEOUS

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Health Choice Generations 1 Tier Gold Effective Date: 11/01/2018.

Quick Guide to Common Antidepressants-Adults

ANTIDIABETIC AGENTS - MISCELLANEOUS

IlliniCare Health MMAI (MMP) 2016 Step Therapy Criteria

Supplementary figures and tables. Figure A: Study schematic

ANTIDIABETIC AGENTS - MISCELLANEOUS

Step Therapy Requirements. Effective: 1/1/2019

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Transcription:

ALPHA BLOCKERS RAPAFLO 4 MG CAPSULE RAPAFLO 8 MG CAPSULE drug may be given. alfuzosin extended release tablet doxazosin tablet tamsulosin capsule terazosin capsule 1

ANTIDEPRESSANTS - SNRI FETZIMA 10 MG FETZIMA 0 MG ()-40 MG (6) CAPSULE,EXTENDED RELEASE,4 HR,DOSE PACK FETZIMA 0 MG FETZIMA 40 MG FETZIMA 80 MG drug may be given. Authorization may be given for a step drug that does not have a generic equivalent included in step 1, without trial of a step 1 drug, if the patient is currently taking or has taken the drug in the past. Authorization may be given for a step drug that does not have a generic equivalent included in step 1, without a trial of a step 1 drug, if the patient has symptoms of suicidal ideation. citalopram tablet citalopram oral solution desvenlafaxine succinate extended release tablet duloxetine capsule escitalopram tablet escitalopram oral solution fluoxetine capsule fluoxetine oral solution fluvoxamine tablet fluvoxamine extended release capsule paroxetine tablet paroxetine extended release tablet sertraline tablet sertraline oral solution venlafaxine tablet venlafaxine extended release capsule

COLCRYS-PST COLCRYS 0.6 MG TABLET Criteria If the patient has tried one Step 1 product, authorization for a Step product may be given. Exceptions can be made for a step drug (without a trial of a step 1 drug) for the treatment of Familial Mediterranean Fever and for the treatment of gout flares (i.e, prophylaxis of gout flares requires a trial of a step 1 drug). MITIGARE CAPSULE 3

OPHTHALMIC PROSTAGLANDINS-PST ZIOPTAN (PF) 0.001 % EYE DROPS IN A DROPPERETTE drug may be given. Authorization for Zioptan may be given if the patient has a known benzalkonium chloride (BAK) sensitivity or a known sensitivity to other ophthalmic preservatives. bimatoprost eye drops latanoprost eye drops LUMIGAN EYE DROPS TRAVATAN Z EYE DROPS 4

TOPICAL ACTINIC KERATOSIS FLUOROURACIL 0. % TOPICAL CREAM ZYCLARA. % TOPICAL CREAM PUMP ZYCLARA 3.7 % TOPICAL CREAM PACKET drug may be given. CARAC TOPICAL CREAM diclofenac 3% topical gel fluorouracil % topical solution fluorouracil % topical solution fluorouracil % topical cream imiquimod topical cream packet

ULORIC ULORIC 40 MG TABLET ULORIC 80 MG TABLET drug may be given. Authorization may be given for Uloric if the patient has renal insufficiency or decreased renal function. Authorization may be given for Uloric if the patient is receiving concomitant medications that have significant drug-drug interactions with allopurinol, which are not noted with Uloric (eg, cyclosporine, chlorpropamide). allopurinol tablet 6

Index C COLCRYS 0.6 MG TABLET... 3 F FETZIMA 10 MG... FETZIMA 0 MG ()-40 MG (6),4 HR,DOSE PACK... FETZIMA 0 MG... FETZIMA 40 MG... FETZIMA 80 MG... FLUOROURACIL 0. % TOPICAL CREAM... R RAPAFLO 4 MG CAPSULE... RAPAFLO 8 MG CAPSULE... U ULORIC 40 MG TABLET... ULORIC 80 MG TABLET... Z ZIOPTAN (PF) 0.001 % EYE DROPS IN A DROPPERETTE... ZYCLARA. % TOPICAL CREAM PUMP... ZYCLARA 3.7 % TOPICAL CREAM PACKET... 1 1 6 6 4 7